| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/01/2000 | EP0981619A1 T1/st2-receptor ligand iii |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981617A1 Recombinant lactoferrin, methods of production from plants and uses |
| 03/01/2000 | EP0981616A1 Ligand polypeptide for the g protein-coupled receptor from human pituitary glands |
| 03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 03/01/2000 | EP0981614A1 Prostate cancer-specific marker |
| 03/01/2000 | EP0981613A1 PARG, A GTPase ACTIVATING PROTEIN WHICH INTERACTS WITH PTPL1 |
| 03/01/2000 | EP0981612A2 Secreted proteins and polynucleotides encoding them |
| 03/01/2000 | EP0981611A1 Polynucleotides encoding proexendin, and methods and uses thereof |
| 03/01/2000 | EP0981610A2 Compositions for treatment of disorders involving programmed cell death |
| 03/01/2000 | EP0981606A2 Method and construct for inhibition of cell migration |
| 03/01/2000 | EP0981603A1 Models for haematopoiesis |
| 03/01/2000 | EP0981602A1 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 03/01/2000 | EP0981599A2 Method for increasing yields or recombinant proteins |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981547A1 Tumor-associated antigen |
| 03/01/2000 | EP0981546A1 Protein smi on hematopoietic stem cells |
| 03/01/2000 | EP0981544A2 Anti-bacterial methods and materials |
| 03/01/2000 | EP0981543A1 Method for detecting hiv antibodies and antigens used to this end |
| 03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
| 03/01/2000 | EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM |
| 03/01/2000 | EP0981537A1 An infectious clone for human parainfluenza virus type 3 |
| 03/01/2000 | EP0981536A1 Fas ligand compositions for treatment of proliferative disorders |
| 03/01/2000 | EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 03/01/2000 | EP0981368A1 Mass spectrometry of colonization factors |
| 03/01/2000 | EP0981361A1 Method of treating sepsis |
| 03/01/2000 | EP0804230B1 Vaccine against mycobacterial infections |
| 03/01/2000 | EP0769020B1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
| 03/01/2000 | EP0618926B1 New peptide derivatives |
| 03/01/2000 | CN1246154A OB fusion protein compositions and methods |
| 03/01/2000 | CN1246151A Mutants of streptococcal toxin A and methods of use |
| 03/01/2000 | CN1246126A Antimicrobially active polypeptides |
| 03/01/2000 | CN1246125A Peptides comprising a T-cell epitope specific to collagen II |
| 03/01/2000 | CN1246069A A stabilized mixture comprising fibrinogen |
| 03/01/2000 | CN1246059A Polymers |
| 03/01/2000 | CN1245721A Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 02/29/2000 | US6031152 Promoter from a lipid transfer protein gene |
| 02/29/2000 | US6031151 Callus-specific promoters |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031149 Exhibit specific phenotypes; for screening compounds which act as antagonists or agonists |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031089 For screening assays for modulators of adenosine triphosphate sensitive channel proteins |
| 02/29/2000 | US6031088 Polycystic kidney disease PKD2 gene and uses thereof |
| 02/29/2000 | US6031087 Nucleotide sequences or complementary sequences of a type ii serine protease inhibitor precursor from a plant; for pathogen resistant transgenic plants |
| 02/29/2000 | US6031081 Process for reactivating purified membrane proteins by freezing them |
| 02/29/2000 | US6031080 Chemotactic cytokine |
| 02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
| 02/29/2000 | US6031078 MTbx protein and nucleic acid molecules and uses therefor |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6031076 Conservin compositions |
| 02/29/2000 | US6031075 Amino acid sequence of synthesized isolated alveolar surfactant protein-b produced by cleaving fusion protein |
| 02/29/2000 | US6031073 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
| 02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
| 02/29/2000 | US6031003 Calcium receptor-active molecules |
| 02/29/2000 | US6030947 Treating p150,95-mediated inflammation which comprises administering an anti-inflammatory agent comprising alpha-subunit of human p150,95 in association with beta-subunit of member of lfa-1 family of receptor molecules |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack |
| 02/29/2000 | US6030832 Dna sequence of protein which interacts with domain of tumor suppressor protein |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030810 Nucleotide and amino acid sequence of voltage-gated transport protein; for diagnosis and therapy of nervous system disorders; antiepileptic agents |
| 02/29/2000 | US6030808 Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof |
| 02/29/2000 | US6030806 Human chromosome 16 genes, compositions, methods of making and using same |
| 02/29/2000 | US6030805 Fibronectin binding protein as well as its preparation |
| 02/29/2000 | US6030804 Nucleotide and amino acid sequences; for prevention and/or treatment of osteoporosis, hypercalcemia, hypoparathyroidism, hypophosphatemia, kidney stones, nephrolithiasis, and chronic tetany |
| 02/29/2000 | US6030799 Immunoassays for detecting chlamydial antigens or antibodies thereto using recombinant or synthetic major outer membrane protein polypeptides as substitute antigens |
| 02/29/2000 | US6030797 Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
| 02/29/2000 | US6030795 Recombinant TGF-β type I receptor variants having differentially diminished capacity to signal for matrix protein production |
| 02/29/2000 | US6030794 Determining subtype or isoform bound by agent by incubating agent with one or more cell lines homozygous for a disruption in one or more of its receptor genes, determining the amount of agent, and comparing to control cells |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030785 Incubating a mixture containing pkr protein kinase, a viral protein containing an interferon sensitivity determining region, and an agent to be tested; then measuring the protein kinase activity where activity indicates an antiviral agent |
| 02/29/2000 | US6030780 Screening drugs that modulate ability of signal transducers and activators of transcription protein dimers to interact and bind dna binding sites by measuring affinity of n-terminal domain to weak and strong binding sites |
| 02/29/2000 | US6030776 Parallel SELEX |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030771 Mosaic protein and restriction endonuclease assisted ligation method for making the same |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030624 Mucosal immunogens for novel vaccines |
| 02/29/2000 | US6030619 Molecular mimetics of meningococcal B epitopes |
| 02/29/2000 | US6030618 Therapeutic and prophylactic methods using heat shock proteins |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | US6030602 Peptide conjugates for transfecting cells |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/29/2000 | CA2168878C Quantitation of carbohydrate deficient transferrin in high alcohol consumption by hplc |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/29/2000 | CA1340916C Method for enhancing production of secondary metabolites using clustered biosynthetic genes |
| 02/29/2000 | CA1340914C Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/24/2000 | WO2000009737A1 Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |